ArticleEuropean urology open science2026
Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.
Jennifer Linehan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.